Dr. Hunger is an internationally recognized expert in leukemia genetics and the treatment of childhood acute lymphoblastic leukemia (ALL). He serves as Chair of the Children's Oncology Group (COG) ALL Disease Committee, which is responsible for the design and conduct of clinical trials and linked laboratory research studies that include over 70% of U.S. and Canadian children with ALL. He is also Principal Investigator on the COG ALL TARGET project, which has identified a number of new molecular abnormalities in childhood ALL that hold promise as targets for new therapies.
Dr. Hunger is the Co-Principal Investigator of the Section of Hematology, Oncology and BMT's NIH-funded T32 grant to train pediatric cancer researchers.